Effect of tranexamic acid on the prognosis of patients with traumatic brain injury undergoing craniotomy: study protocol for a randomised controlled trial

INTRODUCTION: Abnormal coagulation function aggravates the prognosis of patients with traumatic brain injury (TBI). It was reported that the antifibrinolytic drug tranexamic acid (TXA) could reduce intracranial haemorrhage and mortality in non-operative patients with TBI. However, there is a lack of...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Bei, Lu, Yu, Yu, Yun, Yue, Hongli, Wang, Jie, Chong, Yingzi, Cui, Weihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Anaesthesia
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8627390/
https://www.ncbi.nlm.nih.gov/pubmed/34824110
http://dx.doi.org/10.1136/bmjopen-2021-049839

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8627390/
https://www.ncbi.nlm.nih.gov/pubmed/34824110
http://dx.doi.org/10.1136/bmjopen-2021-049839

Ejemplares similares